Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)
This study is currently recruiting participants.
Verified May 2009 by Queen Mary University of London
Sponsor:
Queen Mary University of London
Collaborator:
Immunomedics, Inc.
Information provided by:
Queen Mary University of London
ClinicalTrials.gov Identifier:
NCT01279707
First received: April 12, 2010
Last updated: January 13, 2012
Last verified: May 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |